Subscribe to Email Alerts
INOVIQ
  • About Us
    • About INOVIQ
    • Market Opportunity
    • Board
    • Management
    • Medical & Scientific Advisory Board
    • Partners
    • Distributors
    • Compliance
    • Careers
  • Technology
    • Our Science
    • NETs Platform
    • SubB2M Platform
    • BARD1 Biomarker Technology
    • hTERT ICC Assay
    • Intellectual Property
    • Publications
    • Resources
    • Business Development
  • Products
    • Our Products
    • EXO-NET® Pan-Exosome
      • Product Overview
      • Technical Information
      • Data & Figures
      • Ordering
    • hTERT ICC Test
  • Pipeline
    • Development Pipeline
    • NeuCA15-3 Test
    • NeuCA125 Test
    • EXO-Ovarian Cancer Test
    • Exosome Therapeutics
  • Investors
    • Investor Overview
    • ASX Announcements
    • Annual & Financial Reports
    • Presentations
    • Share Price Information
    • AGM
    • INOVIQ Fact Sheet
    • Corporate Governance
    • Shareholder Services
    • FAQ
    • Analyst Reports
  • News & Events
    • INOVIQ in the News
    • Conferences & Events
  • Contact
    • Contact Us
    • Subscribe to Email Alerts

INOVIQ in the News

Heading &

Sub-heading can be edited through HQI

News & Events > INOVIQ in the News
  • INOVIQ in the News
  • Conferences & Events

INOVIQ in the News

Filter by Year:2025 2024 2023 2022 2021 2020 2018 2017 
23-Oct-2018
Proactive Investors covers INOVIQ breast cancer test announcement today INOVIQ develops world’s first blood test for early detection of breast cancer
23-Oct-2018
Article published by SmallCaps today INOVIQ develops world first blood test for breast cancer detection
21-May-2018
Article published by StocksDigital in nextBIOTECH Top Results: INOVIQ Continues to Boost its Ovarian Cancer Detection Studies
21-May-2018
Article published by finfeed INOVIQ inks critical deal to develop autoantibody test
18-May-2018
Interview of INOVIQ CEO Dr Leearne Hinch by Proactive Investors INOVIQ approaching “important milestone” on path to commercialisation
18-May-2018
Article published by Proactive Investors INOVIQ signs agreement to develop custom research assay
10-Jan-2018
INOVIQ announces positive results from ovarian cancer test
9-Jan-2018
Article published by SMALL CAPS on INOVIQ’s Ovarian Cancer Detection Study
  • 1

Quick Links

Contact Us

Melbourne:
T: +61 3 9548 7586
23 Normanby Road
Notting Hill VIC 3168
Australia

US Office:
987 Old Eagle School Road, Suite 709
Wayne, PA 19087

Online:
E: [email protected]
W: www.inoviq.com

Email Alerts

Subscribe to Email Alerts

Follow Us

Copyright © INOVIQ
Site Map Privacy Search
Site by